RNA, U6 small nuclear 1065, pseudogene (RNU6-1065P)

RNA, U6 small nuclear 1065, pseudogene (RNU6-1065P) is a **pseudogene** locus corresponding to the U6 small nuclear RNA gene family. Pseudogenes are defective copies of functional genes; while they share sequence similarity with the parent gene, they generally lack protein-coding potential due to disabling mutations or truncations, and are not transcribed into functional products[1][2]. In some cases, pseudogenes may have regulatory roles, such as generating non-coding RNAs or acting as microRNA decoys, but there is no evidence that RNU6-1065P has such a function[1][2][3]. RNU6-1065P is not considered a therapeutic target, receptor, enzyme, transporter, or any main molecular target class. There is no known role for this pseudogene in disease, no associated therapeutic interventions, drugs, biomarkers, or safety concerns[1][2]. Additional context and clarification: - U6 small nuclear RNA genes encode a component of the spliceosome; however, pseudogene forms such as RNU6-1065P are *nonfunctional* and typically do not contribute to splicing[1][2]. - The “RNA, U6 small nuclear [number], pseudogene” naming convention refers to one of many nonfunctional sequence variants scattered throughout the genome, distinguished by their number (here, 1065), with no evidence for individual biological or clinical relevance. - There is nothing unique to suggest RNU6-1065P is a validated biological target or of therapeutic interest; its status as a pseudogene and lack of established function make it irrelevant for drug discovery[1][2][3]. - If you are seeking information on functional U6 small nuclear RNA (snRNA), you should refer to the canonical, non-pseudogene U6 snRNA genes.

Other names

RNU6-1065P